University of Notre Dame
Department of Chemical and Biomolecular Engineering
The Bilgicer Group
R
ESEARCH
P
EOPLE
C
OURSES
P
UBLICATIONS
I
N THE NEWS
C
OLLABORATORS
U
SEFUL LINKS
C
ONTACT US
I
n
T
he
N
ews
2012
Global Medical Discovery :
Small-Molecule-Based Affinity Chromatography Method for Antibody Purification via Nucleotide Binding Site Targeting
Faculty of 1000 :
Small-Molecule-Based Affinity Chromatography Method for Antibody Purification via Nucleotide Binding Site Targeting
Indiana Clinical and Translational Sciences Institute :
Nanoparticles engineered at Notre Dame promise to improve blood cancer treatment
Expert Review of Hematology :
Engineered Nanoparticles may Improve Multiple Myeloma Treatment
Nanomedicine :
Engineered Nanoparticles may Improve Multiple Myeloma Treatment
Materials Today :
Designer Nanoparticles to Treat Blood Cancer
C&EN News :
Method Better Pins Down Antibodies
Genetic Engineering & Biotechnology News :
Nanoparticle Delivers Chemotherapy Directly to Multiple Myeloma and Prevents CAM-DR
Notre Dame College of Engineering News :
Nanoparticles engineered at Notre Dame promise to improve blood cancer treatment
Notre Dame News :
Nanoparticles engineered at Notre Dame promise to improve blood cancer treatment
The Scientist :
Pure Pursuits: Techniques for simpler, cheaper, and better antibody purification
The Economic Times :
An end to allergies: New drug could block reactions to anything from pollen to penicillin
BBC Knowledge :
An end to allergies?
(
p
df)
2011
Nature SciBX :
Heterobivalent IgE ligands for the treatment and prevention of allergy
AAAS Science Update :
Pre-empting Allergies
Medical News Today :
A New Way Engineered To Inhibit Allergic Reactions Without Side Effects
Next Big Future :
Researchers engineer new way to inhibit allergic reactions without side effects
Science Daily :
Inhibiting Allergic Reactions Without Side Effects
R&D Magazine :
Researchers engineer new way to inhibit allergic reactions without side effects
BioQuick News :
Breakthrough Approach to Allergy Treatment
Notre Dame News :
Researchers engineer new way to inhibit allergic reactions without side effects
Amplitude :
Focus On Biomedical Engineering
2010
Fox 28 :
Grants awarded for Indiana based initiatives
South Bend Tribune :
Researcher Bilgicer using nanotechnology to improve cancer treatment
Notre Dame Magazine :
Smart drugs target disease
Notre Dame News :
Notre Dame researchers receive medical technologies grants for Indiana-based initiatives
Scope IU School of Medicine Newsletter :
Indiana CTSI Grants
Harvard Gazette :
Using nanotechnology to improve a cancer treatment
Harvard Gazette :
Improving a cancer drug
Indian Express : From an old anti-cancer drug, new hope
AD&T News :
AD&T scientist among Notre Dame researchers receiving medical technologies grants
The Bilgicer Group, 182 Fitzpatrick Hall, Rm A69, Notre Dame, IN 46556 | Phone: 574.631.1341 | Updated: December 7, 2012